Effect of transurethral resection of prostate on prostatic resistive index

Urologia Internationalis

Volumn 84, Issue 2, 2010, Pages 191-193

  Ozden, Cuneyt ^a   Gunay, Isa ^a   Deren, Tagmac ^a   Bulut, Suleyman ^a   Ozdal, Ozdem Levent ^a   Koparal, Suha ^a   Memis, Ali ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Benign prostatic hyperplasia; Power Doppler imaging; Resistive index; Transrectal ultrasonography; Transurethral resection of prostate

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; DOPPLER ECHOGRAPHY; FOLLOW UP; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MALE; MEDICAL PARAMETERS; ORGAN SIZE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROSTATIC RESISTIVE INDEX; TRANSURETHRAL RESECTION; URINE FLOW RATE; UROFLOWMETRY;

AGED; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC HYPERPLASIA; RHEOLOGY; TRANSURETHRAL RESECTION OF PROSTATE; ULTRASONOGRAPHY, DOPPLER; UROLOGY;

EID: 77949391683     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000277597     Document Type: Article

References (20)

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL: The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-479.
2. Emberton M, Cornel EB, Bassi PF, Fourcade RO, Gómez JM, Castro R: Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management. Int J Clin Pract 2008; 62: 1076-1086.
3. DiSantostefano RL, Biddle AK, Lavelle JP: An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia. BJU Int 2006; 97: 1007-1016.
4. Wendt-Nordahl G, Bucher B, Häcker A, Knoll T, Alken P, Michel MS: Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center. J Endourol 2007; 21: 1081-1087.
5. Varkarakis J, Bartsch G, Horninger W: Longterm morbidity and mortality of transurethral prostatectomy: a 10-year follow-up. Prostate 2004; 58: 248-251.
6. Scarpa RM: Lower urinary tract symptoms: what are the implications for the patients? Eur Urol 2001; 40(suppl 4):12-20.
7. Porru D, Madeddu G, Campus G, Montisci I, Scarpa RM, Usai E: Evaluation of morbidity of multi-channel pressure-flow studies. Neurourol Urodyn 1999; 18: 647-652.
8. Kortmann BB, Sonke GS, D'ancona FC, Floratos DL, Debruyne FM, De La Rosette JJ: The tolerability of urodynamic studies and flexible cysto-urethroscopy used in the assessment of men with lower urinary tract symptoms. BJU Int 1999; 84: 449-453.
9. Tsuru N, Kurita Y, Masuda H, Suzuki K, Fujita K: Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy. Int J Urol 2002; 9: 427-430.
10. Kojima M, Watanabe H, Watanabe M, Okihara K, Naya Y, Ukimura O: Preliminary results of power Doppler imaging in benign prostatic hyperplasia. Ultrasound Med Biol 1997; 23: 1305-1309.
11. Ozdemir H, Onur R, Bozgeyik Z, Orhan I, Ogras MS, Ogur E: Measuring resistance index in patients with BPH and lower urinary tract symptoms. J Clin Ultrasound 2005; 33: 176-180.
12. Amiel GE, Slawin KM: Newer modalities of ultrasound imaging and treatment of the prostate. Urol Clin North Am 2006; 33: 329-337.
13. Murphy KJ, Rubin JM: Power Doppler: it's a good thing. Semin Ultrasound CT MR 1997; 18: 13-21.
14. Kojima M, Ochiai A, Naya Y, Okihara K, Ukimura O, Miki T: Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction. Eur Urol 2000; 37: 436-442.
15. Rubin JM, Adler RS: Power Doppler expands standard color capability. Diagn Imaging (San Franc) 1993; 15: 66-69.
16. Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS: Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US. Radiology 1994; 190: 853-856.
17. Hayami S, Ushiyama T, Kurita Y, Kageyama S, Suzuki K, Fujita K: The value of power Doppler imaging to predict the histologic components of benign prostatic hyperplasia. Prostate 2002; 53: 168-174.
18. Kojima M, Ochiai A, Naya Y, Ukimura O, Watanabe M, Watanabe H: Correlation of presumed circle area ratio with infravesical obstruction in men with lower urinary tract symptoms. Urology 1997; 50: 548-555.
19. Berger AP, Horninger W, Bektic J, Pelzer A, Spranger R, Bartsch G, Frauscher F: Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease? BJU Int 2006; 98: 587-590.
20. Tsuru N, Kurita Y, Suzuki K, Fujita K: Resistance index in benign prostatic hyperplasia using power Doppler imaging and clinical outcomes after transurethral vaporization of the prostate. Int J Urol 2005; 12: 264-269.